Meadow Creek Investment Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.01M Buy
57,260
+308
+0.5% +$6.23K 0.02% 486
2019
Q2
$1.22M Buy
56,952
+4,340
+8% +$91K 0.02% 441
2019
Q1
$1.25M Buy
52,612
+6,020
+13% +$137K 0.03% 404
2018
Q4
$916K Buy
46,592
+3,108
+7% +$55.4K 0.02% 450
2018
Q3
$770K Buy
+43,484
New +$848K 0.02% 556
2017
Q4
Sell
-17,108
Closed -$414K 1323
2017
Q3
$414K Buy
+17,108
New +$455K 0.01% 664

Other funds holding EXEL

Meadow Creek Investment Management's EXEL Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Exelixis (EXEL) stake by 0.54% in Q3 2019, buying an estimated $6.23K and bringing the position to 57,260 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #486.

Meadow Creek Investment Management first reported a position in EXEL in Q3 2017 and has held it in 6 quarters since. The position peaked at $1.25M in Q1 2019. 340 funds tracked by Wall St. Rank hold EXEL as of Q3 2019.

  • Meadow Creek Investment Management held 57,260 shares of Exelixis worth $1.01M as of Q3 2019.
  • Meadow Creek Investment Management bought 308 Exelixis shares in Q3 2019, an estimated $6.23K.
  • Exelixis made up 0.02% of Meadow Creek Investment Management's portfolio in Q3 2019, its #486 holding.
  • Meadow Creek Investment Management first reported a position in Exelixis in Q3 2017 and has held it in 6 quarters since.
  • Meadow Creek Investment Management's Exelixis position peaked at $1.25M in Q1 2019.
  • 340 funds tracked by Wall St. Rank held Exelixis as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.